PDF icon PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · South Asian J Cancer
DOI: 10.1055/s-0045-1805082
Original Article

Evaluation of Radiotherapy Practice in Patients Aged over 80: A Retrospective Study

Harun Demir 
1   Department of Radiation Oncology, Konya City Hospital, Konya, Turkey
,
İbrahim Babalıoğlu
1   Department of Radiation Oncology, Konya City Hospital, Konya, Turkey
,
İlyas Akkar
2   Department of Geriatrics, Konya City Hospital, Konya, Turkey
,
Muhammet Cemal Kızılarslanoğlu
2   Department of Geriatrics, Konya City Hospital, Konya, Turkey
› Institutsangaben
› Weitere Informationen
Auch verfügbar aufeRef
  Lizenzen und Reprints
Preview

Abstract

Background

The study aims to evaluate the survival outcomes, survival-related prognostic factors, and treatment compliance in cancer patients aged ≥80 years treated with radiotherapy (RT).

Methods

The records of 76 patients who received RT at a single center between August 2021 and May 2024 were retrospectively evaluated. Patient and tumor characteristics and treatment details were collected from medical records.

Results

The median age of the patients was 83 years (range: 80–92 years). According to the purpose of RT, palliative (53.8%), definitive (18.4%), and adjuvant (15.8%) RT were most frequently administered, respectively. The median overall survival (OS) in all patients was 10 months. The median OS in patients receiving curative (definitive and adjuvant RT) and palliative RT was 25.1 and 7.2 months, respectively. Poor performance status (PS), leukocyte count prior to RT, compliance, and hospitalization status in the curative group and poor PS, RT compliance, hospitalization status, and new distant recurrence in the palliative group were associated with decreased OS. The majority of patients showed full compliance with the RT process (69.7%). The rate of full compliance with the treatment process was significantly higher in patients with good PS and receiving outpatient treatment. RT-related high-grade toxicity (grade 3–4) was not observed.

Conclusion

This study demonstrates that RT can be used effectively and safely for both palliative and curative purposes in cancer patients aged ≥80 years. The optimization of patient selection and ultimately improvement of treatment outcomes will be facilitated by the support of these results with multicenter studies.

Keywords

older patients - malignancy - octogenarians - overall survival - radiotherapy

Authors' Contributions

The concept and design of the study were developed by H.D., İ.B., İ.A., M.C.K. Acquisition and analysis of data were done by H.D., İ.B., and İ.A. Drafting of the manuscript was done by H.D., İ.B., and M.C.K. Critical review of the manuscript was done by H.D., İ.B., İ.A., and M.C.K.




Publikationsverlauf

Eingereicht: 27. Januar 2025

Angenommen: 06. Februar 2025

Artikel online veröffentlicht:
07. März 2025

© 2025. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India